Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji

Author:

Henderson Alasdair D1,Aubry Maite2,Kama Mike34,Vanhomwegen Jessica5,Teissier Anita2,Mariteragi-Helle Teheipuaura2,Paoaafaite Tuterarii2,Teissier Yoann6,Manuguerra Jean-Claude5ORCID,Edmunds John1,Whitworth Jimmy1,Watson Conall H1,Lau Colleen L7,Cao-Lormeau Van-Mai2,Kucharski Adam J1ORCID

Affiliation:

1. Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

2. Institut Louis Malardé, Papeete, French Polynesia

3. Fiji Centre for Communicable Disease Control, Suva, Fiji

4. The University of the South Pacific, Suva, Fiji

5. Institut Pasteur, Paris, France

6. Direction de la Santé de la Polynésie française, Papeete, French Polynesia

7. Australian National University, Canberra, Australia

Abstract

It has been commonly assumed that Zika virus (ZIKV) infection confers long-term protection against reinfection, preventing ZIKV from re-emerging in previously affected areas for several years. However, the long-term immune response to ZIKV following an outbreak remains poorly documented. We compared results from eight serological surveys before and after known ZIKV outbreaks in French Polynesia and Fiji, including cross-sectional and longitudinal studies. We found evidence of a decline in seroprevalence in both countries over a two-year period following first reported ZIKV transmission. This decline was concentrated in adults, while high seroprevalence persisted in children. In the Fiji cohort, there was also a significant decline in neutralizing antibody titres against ZIKV, but not against dengue viruses that circulated during the same period.

Funder

Ministry for Europe and Foreign Affairs

Horizon 2020 - Research and Innovation Framework Programme

Investissement d'Avenir Program

Wellcome

Medical Research Council

National Health and Medical Research Council

Ministry of Europe and Foreign Affairs

French and French Polynesia government MA’I’ORE program

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3